Furthermore, we report that siRNA‐mediated down‐regulation of PlGF ameliorates liver fibrosis, inflammation and angiogenesis, and inhibits activation of HSCs both in vivo and in vitro. This evidence concerns the gene PGF and Hepatic fibrosis.